AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The podcast discusses the potential impact of weight management drugs on other industries, focusing on a study showing how Eli Lilly's ZEPP may reduce the severity of sleep apnea, affecting MedTech company ResMed. This revelation has caused ResMed's shares to drop by 10%, highlighting the significance of developments in the medical field for companies like ResMed, particularly in the context of competitive dynamics.